CRWSMEDIUM SIGNALFINANCIAL10-K

CRWS completed an $18M acquisition of Baby Boom Consumer Products in July 2024, funded through debt financing, while experiencing declining equity and cash positions alongside improved operating cash flow.

The Baby Boom acquisition represents a meaningful expansion of the company's infant and juvenile products portfolio, but the $8M term loan financing contributed to higher current liabilities and reduced financial flexibility. The improved operating cash flow provides some reassurance about the company's ability to service its increased debt load and integrate the new acquisition.

Comparing 2025-06-25 vs 2024-06-28View on EDGAR →
FINANCIAL ANALYSIS

The company's balance sheet shows signs of strain from the acquisition financing, with current liabilities increasing 48% to $15.5M while cash declined 37% to just $521K and stockholders' equity fell 23% to $39.6M. However, operating cash flow grew meaningfully to $9.8M from $7.1M, suggesting the underlying business is generating stronger cash returns. SG&A expenses rose modestly by 16% to $18.7M, likely reflecting both acquisition integration costs and the expanded business scope.

FINANCIAL STATEMENT CHANGES
Current Liabilities
Balance Sheet
+48.2%
$10.5M$15.5M

Current liabilities surged 48.2% — significant near-term obligations; verify ability to meet short-term debt.

Operating Cash Flow
Cash Flow
+38.6%
$7.1M$9.8M

Operating cash flow surged 38.6% — exceptional cash generation, highest quality earnings signal.

Cash & Equivalents
Balance Sheet
-37.2%
$829K$521K

Cash declined 37.2% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.

Stockholders Equity
Balance Sheet
-23.2%
$51.6M$39.6M

Equity decreased 23.2% — buybacks or losses reducing book value, monitor solvency ratios.

SG&A Expense
P&L
+16.1%
$16.1M$18.7M

SG&A increased modestly — likely reflects growth-related hiring or sales expansion investment.

LANGUAGE CHANGES
NEW — 2025-06-25
PRIOR — 2024-06-28
ADDED
As of May 31, 2025, 10,567,543 shares of the registrant s common stock were outstanding.
The infant, toddler and juvenile products segment consists of infant and toddler bedding, diaper bags, bibs, disposables, toys and feeding products.
References herein to fiscal year 2025 or 2025 represent the 52-week period ended March 30, 2025, and references herein to fiscal year 2024 or 2024 represent the 52-week period ended March 31, 2024.
On July 19, 2024 , NoJo acquired substantially all of the assets, and assumed certain specified liabilities, of Baby Boom Consumer Products, Inc.
(the Acquisition ), for a purchase price of $18.0 million in cash, subject to a dollar-for-dollar adjustment to the extent that the working capital at closing was greater or less than the target working capital of approximately $6.5 million.
+7 more — sign up free →
REMOVED
As of May 31, 2024, 10,310,719 shares of the registrant s common stock were outstanding.
All written or oral forward-looking statements that are made by or are attributable to the Company are expressly qualified in their entirety by this cautionary notice.
The infant, toddler and juvenile products segment consists of infant and toddler bedding and blankets, bibs, soft bath products, disposable products, developmental toys and accessories.
References herein to fiscal year 2024 or 2024 represent the 52-week period ended March 31, 2024, and references herein to fiscal year 2023 or 2023 represent the 52-week period ended April 2, 2023.
On March 17, 2023 (the Closing Date ), the Company acquired Manhattan Group, LLC ( Manhattan ) and MTE, Manhattan s then wholly-owned subsidiary (the Manhattan Acquisition ), for a purchase price of $17.0 million, subject to adjustments for cash as of the Closing Date and to the extent that actual net working capital as of the Closing Date differed from target net working capital of $13.75 million.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →